Abstract
Staphylococcins are antimicrobial peptides or proteins produced by staphylococci. They can be separated into different classes, depending on their amino acid composition, structural complexity, and steps involved in their production. In this review, an overview of the current knowledge on staphylococcins will be presented with emphasis on the information collected in the last decade, including a brief description of new peptides. Most staphylococcins characterized to date are either lantibiotics or linear class II bacteriocins. Recently, gene clusters coding for production of circular bacteriocins, sactipeptides, and thiopeptides have been mined from the genome of staphylococcal isolates. In contrast to class II bacteriocins, lantibiotics, sactipeptides, and thiopeptides undergo post-translational modifications that can be quite extensive, depending on the peptide. Few staphylococcins inhibit only some staphylococcal species, but most of them have proven to target pathogens belonging to different genera and involved in a variety of infectious diseases of clinical or agronomic importance. Therefore, these peptides exhibit potential application as anti-infective drugs in different areas. This review will also cover this diverse and remarkable potential. To be commercialized, however, staphylococcin production should be cost-effective and result in high bacteriocin yields, which are not generally achieved from the culture supernatant of their native producers. Such low yields make their production quite costly and not suitable at large industrial scale. Efforts already made to overcome this limitation, minimizing costs and time of production of some staphylococcins and employing either chemical synthesis or in vivo biosynthesis, will be addressed in this review as well.
Key points
• Staphylococci produce a variety of antimicrobial peptides known as staphylococcins.
• Most staphylococcins are post-translationally modified peptides.
• Staphylococcins exhibit potential biotechnological applications.
Graphical abstract
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abriouel H, Franz CM, Ben Omar N, Gálvez A (2011) Diversity and applications of Bacillus bacteriocins. FEMS Microbiol Rev 35:201–232. https://doi.org/10.1111/j.1574-6976.2010.00244.x
Acedo JZ, van Belkum MJ, Lohans CT, Towle KM, Miskolzie M, Vederas JC (2016) Nuclear magnetic resonance solution structures of lacticin Q and aureocin A53 reveal a structural motif conserved among leaderless bacteriocins with broad-spectrum activity. Biochemistry 55:733–742. https://doi.org/10.1021/acs.biochem.5b01306
Acedo JZ, Chiorean S, Vederas JC, van Belkum MJ (2018) The expanding structural variety among bacteriocins from Gram-positive bacteria. FEMS Microbiol Rev 42:805–828. https://doi.org/10.1093/femsre/fuy033
Aires-de-Sousa M (2017) Methicillin-resistant Staphylococcus aureus among animals: current overview. Clin Microbiol Infect 23:373–380. https://doi.org/10.1016/j.cmi.2016.11.002
Akasapu S, Hinds AB, Powell WC, Walczak MA (2019) Total synthesis of micrococcin P1 and thiocillin I enabled by Mo(VI) catalyst. Chem Sci 10:1971–1975. https://doi.org/10.1039/c8sc04885a
Allgaier H, Jung G, Werner RG, Schneider U, Zähner H (1986) Epidermin: sequencing of a heterodet tetracyclic 21-peptide amide antibiotic. Eur J Biochem 160:9–22. https://doi.org/10.1111/j.1432-1033.1986.tb09933.x
Álvarez R, Cortés LEL, Molina J, Cisneros JM, Pachón J (2016) Optimizing the clinical use of vancomycin. Antimicrob Agents Chemother 60:2601–2609. https://doi.org/10.1128/AAC.03147-14
Alvarez-Sieiro P, Montalbán-López M, Um D, Kuipers OP (2016) Bacteriocins of lactic acid bacteria: extending the family. Appl Microbiol Biotechnol 100:2939–2951. https://doi.org/10.1007/s00253-016-7343-9
Argudín MA, Deplano A, Meghraoui A, Dodémont M, Heinrichs A, Denis O, Nonhoff C, Roisin S (2017) Bacteria from animals as a pool of antimicrobial resistance genes. Antibiotics 6:12. https://doi.org/10.3390/antibiotics6020012
Arnison PG, Bibb MJ, Bierbaum G, Bowers AA, Bugni TS, Bulaj G, Camarero JA, Campopiano D, Challis GL, Clardy J, Cotter PD, Craik DJ, Dawson M, Dittmann E, Donadio S, Dorrestein PC, Entian K-D, Fischbach MA, Garavelli JS, Göransson U, Gruber CW, Haft DH, Hemscheidt TK, Hertweck C, Hill C, Horswill AR, Jaspars M, Kelly WL, Klinman JP, Kuipers OP, Link AJ, Liu W, Marahiel MA, Mitchell DA, Moll GN, Moore BS, Müller R, Nair SK, Nes IF, Norris GE, Olivera BM, Onaka H, Patchett ML, Piel J, Reaney MJT, Rebuffat S, Ross RP, Sahl H-G, Schmidt EW, Selsted ME, Severinov K, Shen B, Sivonen K, Smith L, Stein T, Süssmuth RD, Tagg JR, Tang GL, Truman AW, Vederas JC, Walsh CT, Walton JD, Wenzel SC, Willey JM, van der Donk WA (2013) Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature. Nat Prod Rep 30:108–160. https://doi.org/10.1039/c2np20085
Asaduzzaman SM, Nagao J, Iida H, Zendo T, Nakayama J, Sonomoto K (2009) Nukacin ISK-1, a bacteriostatic lantibiotic. Antimicrob Agents Chemother 53:3595–3598. https://doi.org/10.1080/09168451.2014.918485
Bali V, Panesar PS, Bera MB (2016) Trends in utilization of agro-industrial byproducts for production of bacteriocins and their biopreservative applications. Crit Rev Biotechnol 36:204–214. https://doi.org/10.3109/07388551.2014.947916
Barbosa J, Caetano T, Mendo SJ (2015) Class I and class II lanthipeptides produced by Bacillus spp. Nat Prod 78:2850–2866. https://doi.org/10.1021/np500424y
Bastos MCF, Ceotto H, Coelho MLV, Nascimento JS (2009) Staphylococcal antimicrobial peptides: relevant properties and potential biotechnological applications. Curr Pharm Biotechnol 10:38–61. https://doi.org/10.2174/138920109787048580
Bastos MCF, Coutinho BG, Coelho MLV (2010) Lysostaphin: a staphylococcal bacteriolysin with potential clinical applications. Pharmaceuticals 3:1139–1161. https://doi.org/10.3390/ph3041139
Becker K, Heilmann C, Peters G (2014) Coagulase-negative staphylococci. Clin Microbiol Rev 27:870–926. https://doi.org/10.1128/CMR.00109-1
Becker K, Skov RL, von Eiff C (2015) Staphylococcus, Micrococcus and other catalase-positive cocci. In: Jorgensen JH, Pfaller MA, Carroll KC, Landry ML, Funke G, Richter SS, Warnock DW (eds) Manual of Clinical Microbiology. ASM Press, Washington, pp 354–382
Bengtsson T, Lönn J, Khalaf H, Palm E (2018) The lantibiotic gallidermin acts bactericidal against Staphylococcus epidermidis and Staphylococcus aureus and antagonizes the bacteria-induced proinflammatory responses in dermal fibroblastos. MicrobiologyOpen 7:e606. https://doi.org/10.1002/mbo3.606
Bennallack PR, Burt SR, Heder MJ, Robison RA, Griffitts JS (2014) Characterization of a novel plasmid-borne thiopeptide gene cluster in Staphylococcus epidermidis strain 115. J Bacteriol 196:4344–4350. https://doi.org/10.1128/JB.02243-14
Bennallack PR, Bewley KD, Burlingame MA, Robison RA, Miller SM, Griffitts JS (2016) Reconstitution and minimization of a micrococcin biosynthetic pathway in Bacillus subtilis. J Bacteriol 198:2431–2438. https://doi.org/10.1128/JB.00396-16
Bierbaum G, Sahl H-G (2009) Lantibiotics: mode of action, biosynthesis and bioengineering. Curr Pharm Biotechnol 10:2–18. https://doi.org/10.2174/138920109787048616
Blazanovic K, Zhao H, Choi Y, Li W, Salvat RS, Osipovitch DC, Fields J, Moise L, Berwin BL, Fiering SN, Bailey-Kellogg C, Griswold KE (2015) Structure-based redesign of lysostaphin yields potent antistaphylococcal enzymes that evade immune cell surveillance. Mol Ther Methods Clin Dev 2:15021. https://doi.org/10.1038/mtm.2015.21
Bommarius B, Jenssen H, Elliott M, Kindrachuk J, Pasupuleti M, Gieren H, Jaeger K-E, Hancock REW, Kalman D (2010) Cost-effective expression and purification of antimicrobial and host defense peptides in Escherichia coli. Peptides 31:1957–1965. https://doi.org/10.1016/j.peptides.2010.08.008
Bounthavong M, Zargarzadeh A, Hsu DI, Vanness DJ (2011) Cost-effectiveness analysis of linezolid, daptomycin, and vancomycin in methicillin-resistant Staphylococcus aureus: complicated skin and skin structure infection using Bayesian methods for evidence synthesis. Value Health 14:631–639. https://doi.org/10.1016/j.jval.2010.12.006
Braem G, Stijlemans B, Van Haken W, De Vliegher S, De Vuyst L, Leroy F (2014) Antibacterial activities of coagulase-negative staphylococcin from bovine teat apex skin and their inhibitory effect on mastitis-related pathogens. J Appl Microbiol 116:1084–1093. https://doi.org/10.1111/jam.12447
Browder HP, Zygmunt WA, Young JR, Tavormina PA (1965) Lysostaphin: enzymatic mode of action. Biochem Biophys Res Commun 19:383–389. https://doi.org/10.1016/0006-291X(65)90473-0
Carnio MC, Höltzel A, Rudolf M, Henle T, Jung G, Scherer S (2000) The macrocyclic peptide antibiotic micrococcin P1 is secreted by the food-borne bacterium Staphylococcus equorum WS 2733 and inhibits Listeria monocytogenes on soft cheese. Appl Environ Microbiol 66:2378–2384. https://doi.org/10.1128/aem.66.6.2378-2384.2000
Carnio MC, Stachelhaus T, Francis KP, Scherer S (2001) Pyridinyl polythiazole class peptide antibiotic micrococcin P1, secreted by foodborne Staphylococcus equorum WS2733, is biosynthesized nonribosomally. Eur J Biochem 268:6390–6400. https://doi.org/10.1046/j.0014-2956.2001.02591.x
Carson DA, Barkema HW, Naushad S, De Buck J (2017) Bacteriocins of non-aureus staphylococci isolated from bovine milk. Appl Environ Microbiol 83:e01015–e01017. https://doi.org/10.1128/AEM.01015-17
Ceotto H, Nascimento JS, Brito MAVP, Bastos MCF (2009) Bacteriocin production by Staphylococcus aureus involved in bovine mastitis in Brazil. Res Microbiol 160:592–599. https://doi.org/10.1016/j.resmic.2009.07.007
Ceotto H, Brede D, Salehian Z, Nascimento JS, Fagundes PC, Nes IF, Bastos MCF (2010a) Aureocins 4185, bacteriocins produced by Staphylococcus aureus 4185: potential application in food preservation. Foodborne Pathog Dis 7:1255–1262. https://doi.org/10.1089/fpd.2010.0578
Ceotto H, Holo H, Costa KFS, Nascimento JS, Salehian Z, Nes IF, Bastos MCF (2010b) Nukacin 3299, a lantibiotic produced by Staphylococcus simulans 3299 identical to nukacin ISK-1. Vet Microbiol 146:124–131. https://doi.org/10.1016/j.vetmic.2010.04.03
Ceotto H, Dias RCS, Nascimento JS, Brito MAVP, Giambiagi-deMarval M, Bastos MCF (2012) Aureocin production is disseminated amongst unrelated Staphylococcus aureus involved in bovine mastitis. Lett Appl Microbiol 54:455–461. https://doi.org/10.1111/j.1472-765X.2012.03226x
Ceotto-Vigoder H, Marques SLS, Santos INS, Alves MDB, Barrias ES, Potter A, Alviano DS, Bastos MCF (2016) Nisin and lysostaphin activity against preformed biofilm of Staphylococcus aureus involved in bovine mastitis. J Appl Microbiol 121:101–114. https://doi.org/10.1111/jam.13136
Chandrakasan G, Rodríguez-Hernández A-I, López-Cuellar MR, Palma-Rodríguez H-M, Chavarría-Hernández N (2017) Bacteriocin encapsulation for food and pharmaceutical applications: advances in the past 20 years. Biotechnol Lett 41:453–469. https://doi.org/10.1007/s10529-018-02635-5
Chen C, Fan H, Huang Y, Peng F, Hang F, Yuan S, Tong Y (2014) Recombinant lysostaphin protects mice from methicillin-resistant Staphylococcus aureus pneumonia. Biomed Res Int 2014:602185. https://doi.org/10.1155/2014/602185
Chikindas ML, Weeks R, Drider D, Chistyakov VA, Dicks LM (2018) Functions and emerging applications of bacteriocins. Curr Opin Biotechnol 49:23–28. https://doi.org/10.1016/j.copbio.2017.07.011
Ch'ng JH, Chong KKL, Lam LN, Wong JJ, Kline KA (2019) Biofilm-associated infection by enterococci. Nat Rev Microbiol 7:82–94. https://doi.org/10.1038/s41579-018-0107-z
Christy MP, Johnson T, McNerlin CD, Woodard J, Nelson AT, Lim B, Hamilton TL, Freiberg KM, Siegel D (2020) Total synthesis of micrococcin P1 through scalable thiazole forming reactions of cysteine derivatives and nitriles. Org Lett 22:2365–2370. https://doi.org/10.1021/acs.orglett.0c00202
Ciufolini MA, Lefranc D (2010) Micrococcin P1: Structure, biology and synthesis. Nat Prod Rep 27:330–342. https://doi.org/10.1039/b919071f
Cladera-Olivera F, Caron GR, Motta AS, Souto AA, Brandelli A (2006) Bacteriocin-like substance inhibits potato soft rot caused by Erwinia carotovora. Can J Microbiol 52:533–539. https://doi.org/10.1139/w05-159
Coelho MLV, Nascimento JS, Fagundes PC, Madureira DJ, Oliveira SS, Brito MAVP, Bastos MCF (2007) Activity of staphylococcal bacteriocins against Staphylococcus aureus and Streptococcus agalactiae involved in bovine mastitis. Res Microbiol 158:625–630. https://doi.org/10.1016/j.resmic.2007.07.002
Coelho MLV, Coutinho BG, Santos OCS, Nes IF, Bastos MCF (2014) Immunity to the Staphylococcus aureus four-peptide bacteriocin aureocin A70 is conferred by AurI, an integral membrane protein. Res Microbiol 165:50–59. https://doi.org/10.1016/j.resmic.2013.11.001
Coelho MLV, Fleming LR, Bastos MCF (2016) Insights into aureocin A70 regulation: participation of regulator AurR, alternative transcription factor σB and phage ϕ11 regulator cI. Res Microbiol 167:90–102. https://doi.org/10.1016/j.resmic.2015.10.004
Coelho MLV, Duarte AFS, Bastos MCF (2017) Bacterial labionin-containing peptides and sactibiotics: unusual types of antimicrobial peptides with potential use in clinical settings (a review). Curr Top Med Chem 17:1177–1198. https://doi.org/10.2174/1568026616666160930144809
Condas LAZ, De Buck J, Nobrega DB, Carson DA, Roy J-P, Keefe GP, DeVries TJ, Middleton JR, Dufour S, Barkema HW (2017) Distribution of non-aureus staphylococci species in udder quarters with low and high somatic cell count, and clinical mastitis. J Dairy Sci 100:5613–5627. https://doi.org/10.3168/jds.2016-12479
Cotter PD, Ross RP, Hill C (2013) Bacteriocins - a viable alternative to antibiotics? Nat Rev Microbiol 11:95–105. https://doi.org/10.1038/nrmicro2937
Cui F, Li G, Huang J, Zhang J, Lu M, Lu W, Huan J, Huang Q (2011) Development of chitosan-collagen hydrogel incorporated with lysostaphin (CCHL) burn dressing with anti-methicillin-resistant Staphylococcus aureus and promotion wound healing properties. Drug Deliv 18:173–180. https://doi.org/10.3109/10717544.2010.509363
Daly KM, Upton M, Sandiford SK, Draper LA, Wescombe PA, Jack RW, O’Connor PM, Rossney A, Götz F, Hill C, Cotter PD, Ross RP, Tagg JR (2010) Production of the Bsa lantibiotic by community-acquired Staphylococcus aureus strains. J Bacteriol 192:1131–1142. https://doi.org/10.1128/JB.01375-09
Degiacomi G, Personne Y, Mondésert G, Ge X, Mandava CS, Hartkoorn RC, Boldrin F, Goel P, Peisker K, Benjak A, Barrio MB, Ventura M, Brown AC, Leblanc V, Bauer A, Sanyal S, Cole ST, Lagrange S, Parish T, Manganelli R (2016) Micrococcin P1 - A bactericidal thiopeptide active against Mycobacterium tuberculosis. Tuberculosis 100:95–101. https://doi.org/10.1016/j.tube.2016.07.011
Desbois AP, Gemmell CG, Coote PJ (2010) In vivo efficacy of the antimicrobial peptide ranalexin in combination with the endopeptidase lysostaphin against wound and systemic meticillin-resistant Staphylococcus aureus (MRSA) infections. Int J Antimicrob Agents 35:559–565. https://doi.org/10.1016/j.ijantimicag.2010.01.016
Dib J, Motok J, Zenoff VF, Ordoñez O, Farías ME (2008) Occurrence of resistance to antibiotics, UV-B, and arsenic in bacteria isolated from extreme environments in high-altitude (above 4400 m) Andean wetlands. Curr Microbiol 56:510–517. https://doi.org/10.1007/s00284-008-9103-2
Dischinger J, Chipalu SB, Bierbaum G (2014) Lantibiotics: promising candidates for future applications in health care. Int J Med Microbiol 304:51–62. https://doi.org/10.1016/j.ijmm.2013.09.003
Donovan DM, Kerr DE, Wall RJ (2005) Engineering disease resistant cattle. Transgenic Res 14:563–567. https://doi.org/10.1007/s11248-005-0670-8
Drider D, Bendali F, Naghmouchi K, Chikindas ML (2016) Bacteriocins: Not only antibacterial agents. Probiotics Antimicro Proteins 8:177–182. https://doi.org/10.1007/s12602-016-9223-0
Duarte AFS, Ceotto H, Coelho MLV, Brito MAVP, Bastos MCF (2013) Identification of new staphylococcins with potential application as food biopreservatives. Food Control 32:313–321. https://doi.org/10.1016/j.foodcont.2012.12.008
Duarte AFS, Ceotto-Vigoder H, Barrias ES, Souto-Padrón TCBS, Nes IF, Bastos MCF (2018) Hyicin 4244, the first sactibiotic described in staphylococci, exhibits an anti-staphylococcal biofilm activity. Int J Antimicrob Agents 51:349–356. https://doi.org/10.1016/j.ijantimicag.2017.06.025
Duman ZE, Ünlü A, Çakar MM, Ünal H, Binay B (2019) Enhanced production of recombinant Staphylococcus simulans lysostaphin using medium engineering. Prep Biochem Biotechnol 49:521–528. https://doi.org/10.1080/10826068.2019.1599393
Ebner P, Reichert S, Luqman A, Krismer B, Popella P, Götz F (2018) Lantibiotic production is a burden for the producing staphylococci. Sci Rep 8:7471. https://doi.org/10.1038/s41598-018-25935-2
Fagundes PC (2014) Characterization of hyicin 3682 and investigation of its potential of biotechnological application towards a tomat phytopathogen. PhD Thesis, Federal University of Rio de Janeiro, Brazil
Fagundes PC, Ceotto H, Potter A, Brito MAVP, Brede D, Nes IF, Bastos MCF (2011) Hyicin 3682, a bioactive peptide produced by Staphylococcus hyicus 3682 with potential applications for food preservation. Res Microbiol 162:1052–1059. https://doi.org/10.1016/j.resmic.2011.10.002
Fagundes PC, Farias FM, Santos OCS, Oliveira NEM, Paz JA, Ceotto-Vigoder H, Alviano DS, Romanos MTV, Bastos MCF (2016a) The antimicrobial peptide aureocin A53 as an alternative agent for biopreservation of dairy products. J Appl Microbiol 121:435–444. https://doi.org/10.1111/jam.13189
Fagundes PC, Farias FM, Santos OCS, Paz JAS, Ceotto-Vigoder H, Alviano DS, Romanos MTV, Bastos MCF (2016b) The four-component aureocin A70 as a promising agent for food biopreservation. Int J Food Microbiol 237:39–46. https://doi.org/10.1016/j.ijfmicro.2016.08.017
Fagundes PC, Santos INS, Francisco MS, Albano RM, Bastos MCF (2017) Genetic and biochemical characterization of hyicin 3682, the first bacteriocin reported for Staphylococcus hyicus. Microbiol Res 198:36–46. https://doi.org/10.1016/j.micres.2017.02.003
Fagundes PC, Francisco MS, Santos INS, Marques-Bastos SLS, Albano RM, Bastos MCF (2019) Draft genome sequence of Staphylococcus agnetis 3682, the producing strain of the broad spectrum lantibiotic agneticin 3682. J Global Antimicrob Resist 19:50–52. https://doi.org/10.1016/j.jgar.2019.08.014
Fan W, Plaut K, Bramley AJ, Barlow JW, Kerr DE (2002) Adenoviral-mediated transfer of a lysostaphin gene into the goat mammary gland. J Dairy Sci 85:1709–1716. https://doi.org/10.3168/jds.S0022-0302(02)74244-6
Farias FM, Nascimento JS, Santos OCS, Bastos MCF (2019) Study of the effectiveness of staphylococcins in biopreservation of Minas fresh (Frescal) cheese with a reduced salt content. Int J Food Microbiol 304:19–31. https://doi.org/10.1016/j.ijffodmicro.2019.05.014
Flores MR, Ordoñez OF, Maldonado J, Farías ME (2009) Isolation of UV-B resistant bacteria from two high altitude Andean lakes (4,400 m) with saline and non saline conditions. J Gen Appl Microbiol 55:447–458. https://doi.org/10.2323/jgam.55.447
Foster TJ (2017) Antibiotic resistance in Staphylococcus aureus. Current status and future prospects. FEMS Microbiol Rev 41:430–449. https://doi.org/10.1093/femsre/fux007
Francisco MS (2019) Aureocin 4185 and aureocyclicin 4185: a study on bacteriocins encoded by the genome of the strain Staphylococcus aureus 4185. PhD Thesis, Federal University of Rio de Janeiro, Brazil
Francisco MS, Farias FM, Santos INS, Marques-Bastos SLS, Albano RM, Bastos MCF (2017) Draft genome sequence of Staphylococcus aureus 4185, a strain that produces aureocyclicin 4185. Genome Announc 5:e01249–e01217. https://doi.org/10.1128/genomeA.01249-17
Gabrielsen C, Brede DA, Nes IF, Diep DB (2014) Circular bacteriocins: biosynthesis and mode of action. Appl Environ Microbiol 80:6854–6862. https://doi.org/10.1128/AEM.02284-14
Geng M, Smith L (2018) Improving the attrition rate of lanthipeptide discovery for commercial applications. Expert Opin Drug Discovery 13:155–167. https://doi.org/10.1080/17460441.2018.1410137
Gharsallaoui A, Oulahal N, Joly C, Degraeve P (2016) Nisin as a food preservative: Part 1: Physicochemical properties, antimicrobial activity, and main uses. Crit Rev Food Sci Nutr 56:1262–1274. https://doi.org/10.1080/10408398.2013.763765
Gibreel TM, Upton M (2013) Synthetic epidermicin NI01 can protect Galleria mellonella larvae from infection with Staphylococcus aureus. J Antimicrob Chemother 268:2269–2273. https://doi.org/10.1093/jac/dkt195
Goldmann O, Medina E (2018) Staphylococcus aureus strategies to evade the host acquired immune response. Int J Med Microbiol 308:625–630. https://doi.org/10.1016/j.ijmm.2017.09.013
Götz F, Perconti S, Popella P, Werner R, Schlag M (2014) Epidermin and gallidermin: Staphylococcal lantibiotics. Int J Med Microbiol 304:63–71. https://doi.org/10.1016/j.ijmm.2013.08.012
Grinter R, Milner J, Walker D (2012) Bacteriocins active against plant pathogenic bacteria. Biochem Soc Trans 40:1498–1502. https://doi.org/10.1042/BST20120206
Grishin AV, Lavrova NV, Lyashchuk AM, Strukova NV, Generalova MS, Ryazanova AV, Shestak NV, Boksha IS, Polyakov NB, Galushkina ZM, Soboleva LA, Vetchinin SS, Pavlov VM, Karyagina AS, Lunin VG (2019) The influence of dimerization on the pharmacokinetics and activity of an antibacterial enzyme lysostaphin. Molecules 24:1879. https://doi.org/10.3390/molecules24101879
Gründling A, Schneewind O (2006) Cross-linked peptidoglycan mediates lysostaphin binding to the cell wall envelope of Staphylococcus aureus. J Bacteriol 188:2463–2472. https://doi.org/10.1128/JB.188.7.2463-2472.2006
Hajiahmadi F, Alikhani MY, Shariatifar H, Arabestani MR, Ahmadvand D (2019) The bactericidal effect of lysostaphin coupled with liposomal vancomycin as a dual combating system applied directly on methicillin-resistant Staphylococcus aureus infected skin wounds in mice. Int J Nanomedicine 14:5943–5955. https://doi.org/10.2147/IJN.S214521
Halliwell S, Warn P, Sattar A, Derrick JP, Upton M (2017) A single dose of epidermicin NI01 is sufficient to eradicate MRSA from the nares of cotton rats. J Antimicrob Chemother 72:778–781. https://doi.org/10.1093/jac/dkw457
Hammami I, Triki MA, Rebai A (2011) Purification and characterization of the novel bacteriocin Bac IH7 with antifungal and antibacterial properties. J Plant Pathol 93:443–454. https://doi.org/10.4454/jpp.v93i2.1200
Haney EF, Mansour SC, Hancock REW (2017) Antimicrobial peptides: an Introduction. Methods Mol Biol 1548:3–22. https://doi.org/10.1007/978-1-4939-6737-7_1
Heath SL, Heath HE, Sloan GL (1987) Plasmid-encoded lysostaphin endopeptidase gene of Staphylococcus simulans biovar staphylolyticus. FEMS Microbiol Lett 44:129–133. https://doi.org/10.1111/j.1574-6968.1987.tb02256.x
Heath HE, Heath SL, Nitterauer JD, Rose KE, Sloan GL (1989) Plasmid-encoded lysostaphin endopeptidase resistance of Staphylococcus simulans biovar staphylolyticus. Biochem Biophys Res Commun 160:1106–1109. https://doi.org/10.1016/s0006-291x(89)80117-2
Heng NCK, Wescombe PA, Burton JP, Jack RW, Tagg JR (2007) The diversity of bacteriocins in Gram-positive bacteria. In: Riley MA, Chavan MA (eds) Bacteriocins: ecology and evolution. Springer Hildberg, Berlim, pp 45–83
Hennekinne JA, Buyser ML, Dragacci S (2012) Staphylococcus aureus and its food poisoning toxins: characterization and outbreak investigation. FEMS Microbiol Rev 36:815–836. https://doi.org/10.1111/j.1574-6976.2011.00311.x
Hertlein T, Sturm V, Lorenz U, Sumathy K, Jakob P, Ohlsen K (2014) Bioluminescence and 19F magnetic resonance imaging visualize the efficacy of lysostaphin alone and in combination with oxacillin against Staphylococcus aureus in murine thigh and catheter-associated infection models. Antimicrob Agents Chemother 58:1630–1638. https://doi.org/10.1128/AAC.01422-13
Holtsmark I, Mantzilas D, Eijsink VGH, Brurberg MB (2006) Purification, characterization, and gene sequence of michiganin A, an actagardine-like lantibiotic produced by the tomato pathogen Clavibacter michiganensis subsp. michiganensis. Appl Environ Microbiol 72:5814–5821. https://doi.org/10.1128/AEM.00639-06
Ingham AB, Moore RJ (2007) Recombinant production of antimicrobial peptides in heterologous microbial systems. Biotechnol Appl Biochem 47:1–9. https://doi.org/10.1042/BA20060207
Jamaluddin N, Stuckey DC, Ariff AB, Wong FWF (2018) Novel approaches to purifying bacteriocin: a review. Crit Rev Food Sci Nutr 58:2453–2465. https://doi.org/10.1080/10408398.2017.1328658
Janek D, Zipperer A, Kulik A, Krismer B, Peschel A (2016) High frequency and diversity of antimicrobial activities produced by nasal Staphylococcus strains against bacterial competitors. PLoS Pathog 12:e1005812. https://doi.org/10.1371/journal.ppat.1005812
Johnson CT, Wroe JA, Agarwal R, Martin KE, Guldberg RE, Donlan RM, Westbladee LF, García AJ (2018) Hydrogel delivery of lysostaphin eliminates orthopedic implant infection by Staphylococcus aureus and supports fracture healing. Proc Natl Acad Sci U S A 115:E4960–E4969. https://doi.org/10.1073/pnas.1801013115
Johnson CT, Sok MCP, Martin KE, Kalelkar PP, Caplin JD, Botchwey EA, García AJ (2019) Lysostaphin and BMP-2 co-delivery reduces S. aureus infection and regenerates critical-sized segmental bone defects. Sci Adv 5:eaaw1228. https://doi.org/10.1126/sciadv.aaw1228
Joo H-S, Cheung GYC, Otto M (2011) Antimicrobial activity of community-associated methicillin-resistant Stahylococcus aureus is caused by phenol-soluble modulin derivatives. J Biol Chem 286:8933–8940. https://doi.org/10.1074/jbc.M111.221382
Juturu V, Wu JC (2018) Microbial production of bacteriocins: Latest research development and applications. Biotechnol Adv 36:2187–2200. https://doi.org/10.1016/j.biotechadv.2018.10.007
Kaletta C, Entian K-D, Kellner R, Jung G, Reis M, Sahl H-G (1989) Pep5, a new lantibiotic: structural gene isolation and prepeptide sequence. Arch Microbiol 152:16–19. https://doi.org/10.1007/BF00447005
Kawada-Matsuo M, Shammi F, Oogai Y, Nakamura N, Sugai M, Komatsuzawa H (2016) C55 bacteriocin produced by ETB-plasmid positive Staphylococcus aureus strains is a key factor for competition with S. aureus strains. Microbiol Immunol 60:139–147. https://doi.org/10.1111/1348-0421.12360
Kazemi-Zaromi S, Baghaee-Ravari S, Khodaygan P, Falahati-Rastegar M (2016) Screening bactericidal effect of Pectobacterium carotovorum subsp. carotovorum strains against causal agent of potato soft rot. J Basic Microbiol 56:196–205. https://doi.org/10.1002/jobm.201500482
Kies S, Vuong C, Hille M, Peschel A, Meyer C, Götz F, Otto M (2003) Control of antimicrobial peptide synthesis by the agr quorum sensing system in Staphylococcus epidermidis: activity of the lantibiotic epidermin is regulated at the level of precursor peptide processing. Peptides 24:329–338. https://doi.org/10.1016/s0196-9781(03)00046-9
Kim PI, Sohng JK, Sung C, Joo H-S, Kim E-M, Yamaguchi T, Park D, Kim B-G (2010) Characterization and structure identification of an antimicrobial peptide, hominicin, produced by Staphylococcus hominis MBBL 2-9. Biochem Biophys Res Commun 399:133–138. https://doi.org/10.1016/j.bbrc.2010.07.024
Knerr PJ, van der Donk WA (2012) Discovery, biosynthesis, and engineering of lantipeptides. Annu Rev Biochem 81:479–505. https://doi.org/10.1146/annurev-biochem-060110-113521
Lampert Y, Kelman D, Nitzan Y, Dubinsky Z, Behar A, Hill RT (2008) Phylogenetic diversity of bacteria associated with the mucus of Red Sea corals. FEMS Microbiol Ecol 64:187–198. https://doi.org/10.1111/j.1574-6941.2008.00458.x
Lauková A, Kandričáková A, Pleva P, Buňková L, Ščerbová J (2017) Effect of lantibiotic gallidermin against biogenic amine-producing faecal staphylococci from ostriches and pheasants. Folia Microbiol 62:229–235. https://doi.org/10.1007/s12223-017-0492-0
Lee M, Yang J, Park S, Jo E, Kim H-Y, Bae Y-S, Windisch MP (2016) Micrococcin P1, a naturally occurring macrocyclic peptide inhibiting hepatitis C virus entry in a pan-genotypic manner. Antivir Res 132:287–295. https://doi.org/10.1016/j.antiviral.2016.07.002
Liu H, Gao Y, Yu LR, Jones RC, Elkins CA, Hart ME (2011) Inhibition of Staphylococcus aureus by lysostaphin-expressing Lactobacillus plantarum WCFS1 in a modified genital tract secretion medium. Appl Environ Microbiol 77:8500–8508. https://doi.org/10.1128/AEM.06755-11
LPSN (2020) List of prokaryotic names with standing in nomenclature—genus Staphylococcus. Available in: https://lpsn.dsmz.de/search?word=Staphylococcus. Access on 09/22/2020.
Lu H-R, Gu M-G, Huang Q, Huang JJ, Lu W-Y, Lu H, Huang Q-S (2013) Hydrogen/deuterium exchange mass spectrometry and site-directed disulfide cross-linking suggest an important dynamic interface between the two lysostaphin domains. Antimicrob Agents Chemother 57:1872–1881. https://doi.org/10.1128/AAC02348-12
Lynch D, O’Connor PM, Cotter PD, Hill C, Field D, Begley M (2019) Identification and characterisation of capidermicin, a novel bacteriocin produced by Staphylococcus capitis. PLoS One 14:e0223541. https://doi.org/10.1371/journal.pone.0223541
Maqueda M, Sánchez-Hidalgo M, Fernández M, Montalbán-López M, Valdivia E, Martínez-Bueno M (2008) Genetic features of circular bacteriocins produced by Gram-positive bacteria. FEMS Microbiol Rev 32:2–22. https://doi.org/10.1111/j.1574-6976.2007.00087.x
Marques-Bastos SLS, Coelho MLV, Ceotto-Vigoder H, Fagundes PC, Almeida GS, Brede DA, Nes IF, Brito MAVP, Bastos MCF (2020) Molecular characterization of aureocin 4181: a natural N-formylated aureocin A70 variant with a broad spectrum of activity. Braz J Microbiol in press. https://doi.org/10.1007/s42770-020-00315z
Masters EA, Trombetta RP, Bentley KLM, Boyce BF, Gill AL, Gill SR, Nishitani K, Ishikawa M, Morita Y, Ito H, Bello-Irizarry SN, Ninomiya M, Brodell JD Jr, Lee CC, Hao SP, Oh I, Xie C, Awad HA, Daiss JL, Owen JR, Kates SL, Schwartz EM, Muthukrishnan G (2019) Evolving concepts in bone infection: redefining “biofilm”, “acute vs. chronic osteomyelitis”, “the immune proteome” and “local antibiotic therapy”. Bone Res 7:20. https://doi.org/10.1038/s41413-019-0061-z
Mathur H, Rea MC, Cotter PD, Hill C, Ross RP (2015) The sactibiotic subclass of bacteriocins: an update. Curr Protein Pept Sci 16:549–558. https://doi.org/10.2174/1389203716666150515124831
Miao J, Pangule RC, Paskaleva EE, Hwang EE, Kane RS, Linhardt RJ, Dordick JS (2011) Lysostaphin-functionalized cellulose fibers with antistaphylococcal activity for wound healing applications. Biomaterials 32:9557–9567. https://doi.org/10.1016/j.biomaterials.2011.08.080
Mirzaei R, Mohammadzadeh R, Alikhani MY, Moghadam MS, Karampoor S, Kazemi S, Barfipoursalar A, Yousefimashouf R (2020) The biofilm-associated bacterial infections unrelated to indwelling devices. IUBMB Life 2020:1–15. https://doi.org/10.1002/iub.2266
Mohimani H, Kersten RD, Liu WT, Wang M, Purvine SO, Wu S, Heather M, Brewer HM, Pasa-Tolic L, Bandeira N, Moore BS, Pevzner PA, Dorrestein PC (2014) Automated genome mining of ribosomal peptide natural products. ACS Chem Biol 9:1545–1551. https://doi.org/10.1021/cb500199h
Nagao J-I, Harada Y, Shioya K, Aso Y, Zendo T, Nakayama J, Sonomoto K (2005) Lanthionine introduction into nukacin ISK-1 prepeptide by co-expression with modification enzyme NukM in Escherichia coli. Biochem Biophys Res Commun 336:507–513. https://doi.org/10.1016/j.bbrc.2005.08.125
Nandi M, MacDonald J, Liu P, Weselowski B, Yuan Z-C (2018) Clavibacter michiganensis spp. michiganensis: bacterial canker of tomato, molecular interactions and disease management. Mol Plant Pathol 19:2036–2050. https://doi.org/10.1111/mpp.12678
Narasimhaswamy N, Bairy I, Shenoy G, Bairy L (2017) In vitro activity of recombinant lysostaphin in combination with linezolid, vancomycin and oxacillin against methicillin-resistant Staphylococcus aureus. Iran J Microbiol 9:208–212
Nascimento JS, Coelho MLV, Ceotto H, Potter A, Fleming LR, Salehian Z, Nes IF, Bastos MCF (2012) Genes involved in immunity to and secretion of aureocin A53, an atypical class II bacteriocin produced by Staphylococcus aureus A53. J Bacteriol 194:875–883. https://doi.org/10.1128/JB.06203-11
Nes IF, Diep DB, Holo H (2007) Bacteriocin diversity in Streptococcus and Enterococcus. J Bateriol 189:1189–1198. https://doi.org/10.1128/JB.01254-06
Netz DJA, Sahl H-G, Marcolino R, Nascimento JS, Oliveira SS, Soares MB, Bastos MCF (2001) Molecular characterisation of aureocin A70, a multiple-peptide bacteriocin isolated from Staphylococcus aureus. J Mol Biol 311:939–949. https://doi.org/10.1006/jmbi.2001.4885
Netz DJA, Pohl R, Beck-Sickinger AG, Selmer T, Pierik AJ, Bastos MCF, Sahl H-G (2002a) Biochemical characterization and genetic analysis of aureocin A53, a new, atypical bacteriocin from Staphylococcus aureus. J Mol Biol 319:745–756. https://doi.org/10.1016/S0022-2836(02)00368-6
Netz DJA, Bastos MCF, Sahl H-G (2002b) Mode of action of the antimicrobial peptide aureocin A53 from Staphylococcus aureus. Appl Environ Microbiol 68:5274–5280. https://doi.org/10.1128/AEM.68.11.5274-5280.2002
Newstead LL, Varjonen K, Nuttall T, Paterson GK (2020) Staphylococcal-produced bacteriocins and antimicrobial peptides: their potential as alternative treatments for Staphylococcus aureus infections. Antibiotics (Basel) 9:40. https://doi.org/10.3390/antibiotics9020040
Nissen-Meyer J, Rogne P, Oppegård C, Haugen HS, Kristiansen PE (2009) Structure-function relationships of the non-lanthionine-containing peptide (class II) bacteriocins produced by Gram-positive bacteria. Curr Pharm Biotechnol 10:10–37. https://doi.org/10.2174/138920109787048661
Nour El-Din HT, Elhosseiny NM, El-Gendy MA, Mahmoud AA, Hussein MM, Attia AS (2020) A rapid lysostaphin production approach and a convenient novel lysostaphin loaded nano-emulgel; as a sustainable low-cost methicillin-resistant Staphylococcus aureus combating platform. Biomolecules 10:435. https://doi.org/10.3390/biom10030435
O’Sullivan JN, O’Connor PM, Rea MC, O’Sullivan O, Walsh CJ, Healy B, Mathur H, Field D, Hill C, Ross RP (2020) Nisin J, a novel natural nisin variant, is produced by Staphylococcus capitis sourced from the human skin microbiota. J Bacteriol 202:e00639–e00619. https://doi.org/10.1128/JB.00639-19
Okuda K, Zendo T, Sugimoto S, Iwase T, Tajima A, Yamada S, Sonomoto K, Mizunoea Y (2013) Effects of bacteriocins on methicillin-resistant Staphylococcus aureus biofilm. Antimicrob Agents Chemother 57:5572–5579. https://doi.org/10.1128/AAC.00888-13
Ongey EL, Neubauer P (2016) Lanthipeptides: chemical synthesis versus in vivo biosynthesis as tools for pharmaceutical production. Microb Cell Factories 15:e97. https://doi.org/10.1186/s12934-016-0502-y
Otto M (2013) Staphylococcal infections: mechanisms of biofilm maturation and detachment as critical determinants of pathogenicity. Annu Rev Med 64:175–188. https://doi.org/10.1146/annurev-med-042711-140023
Otto M (2014) Staphylococcus aureus toxins. Curr Opin Microbiol 17:32–37. https://doi.org/10.1016/j.mib.2013.11.004
Perez RH, Zendo T, Sonomoto K (2018) Circular and leaderless bacteriocins: Biosynthesis, mode of action, applications, and prospects. Front Microbiol 9:2085. https://doi.org/10.3389/fmicb.2018.02085
Perry JA, Jones MB, Peterson SN, Cvitkovitch DG, Lévesque CM (2009) Peptide alarmone signalling triggers an auto-active bacteriocin necessary for genetic competence. Mol Microbiol 72:905–917. https://doi.org/10.1111/j.1365-2958.2009.06693.x
Peschel A, Augustin J, Kupke T, Stevanovic S, Götz F (1993) Regulation of epidermin biosynthetic genes by EpiQ. Mol Microbiol 9:31–39. https://doi.org/10.1111/j.1365-2958.1993.tb01666.x
Petersen J, Boysen A, Fogh L, Tabermann K, Kofoed T, King A, Schrotz-King P, Hansen MC (2009) Identification and characterization of a bioactive lantibiotic produced by Staphylococcus warneri. Biol Chem 390:437–444. https://doi.org/10.1515/BC.2009.062
Pieta P, Majewska M, Su Z, Grossutti M, Wladyka B, Piejko M, Lipkowski J, Mak P (2016) Physicochemical studies on orientation and conformation of a new bacteriocin BacSp222 in a planar phospholipid bilayer. Langmuir 32:5653–5662. https://doi.org/10.1021/acs.langmuir.5b04741
Potter A, Ceotto H, Coelho MLV, Guimarães AJ, Bastos MCF (2014) The gene cluster of aureocyclicin 4185: the first cyclic bacteriocin of Staphylococcus aureus. Microbiology 160:917–928. https://doi.org/10.1099/mic.0.075689-0
Príncipe A, Fernandez M, Torasso M, Godino A, Fischer S (2018) Effectiveness of tailocins produced by Pseudomonas fluorescens SF4c in controlling the bacterial-spot disease in tomatoes caused by Xanthomonas vesicatoria. Microbiol Res 212-213:94–102. https://doi.org/10.1016/j.micres.2018.05.010
Rahmdel S, Shekarforoush SS, Hosseinzadeh S, Torriani S, Gatto V (2019) Antimicrobial spectrum activity of bacteriocinogenic Staphylococcus strains isolated from goat and sheep milk. J Dairy Sci 102:2928–2940. https://doi.org/10.3168/jds.2018-15414
Raz A, Serrano A, Thaker M, Alston T, Fischetti VA (2018) Lysostaphin lysibody leads to effective opsonization and killing of methicillin-resistant Staphylococcus aureus in a murine model. Antimicrob Agents Chemother 62:e01056–e01018. https://doi.org/10.1128/AAC.01056-18
Rea MC, Ross RP, Cotter PD, Hill C (2011) Classification of bacteriocins from Gram-positive bacteria. In: Drider D, Rebuffat R (eds) Prokaryotic antimicrobial peptides. Springer, New York, pp 29–74
Rogers MJ, Cundliffe E, McCutchan TF (1998) The antibiotic micrococcin is a potent inhibitor of growth and protein synthesis in the malaria parasite. Antimicrob Agents Chemother 42:715–716
Romanovskaia VA, Parfenova VV, Belkova NL, Sukhanova EV, Gladka GV, Tashireva AA (2014) Phylogenetic analysis of bacteria of extreme ecosystems. Mikrobiol Z 76:2–10
Rossi CC, Pereira MF, Giambiagi-deMarval M (2020) Underrated Staphylococcus species and their role in antimicrobial resistance spreading. Genet Mol Biol 43(1(suppl 2)):e20190065. https://doi.org/10.1590/1678-4685-GMB-2019-0065
Roy U, Islam MR, Nagao J, Iida H, Mahin A-A, Li M, Zendo T, Nakayama J, Sonomoto K (2014) Bactericidal activity of nukacin ISK-1: an alternative mode of action. Biosci Biotechnol Biochem 78:1270–1273. https://doi.org/10.1080/09168451.2014.918485
Ruegg PL (2017) A 100-year review: mastitis detection, management, and prevention. J Dairy Sci 100:10381–10397. https://doi.org/10.3168/jds.2017-13023
Sabala I, Jagielska E, Bardelang PT, Czapinska H, Dahms SO, Sharpe JA, James R, Than ME, Thomas NR, Bochtler M (2014) Crystal structure of the antimicrobial peptidase lysostaphin from Staphylococcus simulans. FEBS J 281:4112–4122. https://doi.org/10.1111/febs.12929
Sadeghi S, Bakhshandeh H, Cohan RA, Peirovi A, Ehsani P, Norouzian D (2019) Synergistic anti-staphylococcal activity of niosomal recombinant lysostaphin-LL-37. Int J Nanomedicine 14:9777–9792. https://doi.org/10.2147/IJN.S230269
Saising J, Dube L, Ziebandt A-K, Voravuthikunchai SP, Nega M, Götz F (2012) Activity of gallidermin on Staphylococcus aureus and Staphylococcus epidermidis biofilms. Antimicrob Agents Chemother 56:5804–5810. https://doi.org/10.1128/AAC.01296-12
Sandiford SK (2014) Advances in the arsenal of tools available enabling the discovery of novel lantibiotics with therapeutic potential. Expert Opin Drug Discovery 9:283–297. https://doi.org/10.1517/17460441.2014.877882
Sandiford S, Upton M (2012) Identification, characterization, and recombinant expression of epidermicin NI01, a novel unmodified bacteriocin produced by Staphylococcus epidermidis that displays potent activity against staphylococci. Antimicrob Agents Chemother 56:1539–1547. https://doi.org/10.1128/AAC.05397-11
Sashihara T, Kimura H, Higuchi T, Adachi A, Matsusaki H, Sonomoto K, Ishizaki A (2000) A novel lantibiotic, nukacin ISK-1, of Staphylococcus warneri ISK-1: cloning of the structural gene and identification of the structure. Biosci Biotechnol Biochem 64:2420–2428. https://doi.org/10.1271/bbb.64.2420
Sashihara T, Dan M, Kimura H, Matsusaki H, Sonomoto K, Ishizaki A (2001) The effect of osmotic stress on the production of nukacin ISK-1 from Staphylococcus warneri ISK-1. Appl Microbiol Biotechnol 56:496–501. https://doi.org/10.1007/s002530100669
Schindler CA, Schuhardt VT (1964) Lysostaphin: A new bacteriolytic agent for the Staphylococcus. Proc Natl Acad Sci U S A 51:414–421. https://doi.org/10.1073/pnas.51.3.414
Schmelcher M, Powell AM, Becker SC, Camp MJ, Donovan DM (2012) Chimeric phage lysins act synergistically with lysostaphin to kill mastitis-causing Staphylococcus aureus in murine mammary glands. Appl Environ Microbiol 78:2297–2305. https://doi.org/10.1128/AEM.07050-11
Septimus EJ, Schweizer ML (2016) Decolonization in prevention of health care-associated infections. Clin Microbiol Rev 29:201–222. https://doi.org/10.1128/CMR.00049-15
Shamloo E, Hosseini H, Abdi Moghadam Z, Larsen MH, Haslberger A, Alebouyeh M (2019) Importance of Listeria monocytogenes in food safety: a review of its prevalence, detection, and antibiotic resistance. Iran J Vet Res 20:241–254
Singh VP (2018) Recent approaches in food bio-preservation - a review. Open Vet J 8:104–111. https://doi.org/10.4314/ovj.v8i1.16
Stavropoulou DA, De Vuyst L, Leroy F (2018) Nonconventional starter cultures of coagulase-negative staphylococci to produce animal-derived fermented foods, a SWOT analysis. J Appl Microbiol 125:1570–1586. https://doi.org/10.1111/jam.14054
Su TL (1948) Micrococcin, an antibacterial substance formed by a strain of Micrococcus. Brit J Exp Pathol 29:473–481
Szweda P, Schielmann M, Frankowska A, Kot B, Zalewska M (2014a) Antibiotic resistance in Staphylococcus aureus strains isolated from cows with mastitis in eastern Poland and analysis of susceptibility of resistant strains to alternative nonantibiotic agents: lysostaphin, nisin and polymyxin B. J Vet Med Sci 76:355–362. https://doi.org/10.1292/jvms.13-0177
Szweda P, Gorczyca G, Tylingo R, Kurlenda J, Kwiecinski J, Milewski S (2014b) Chitosan-protein scaffolds loaded with lysostaphin as potential antistaphylococcal wound dressing materials. J Appl Microbiol 117:634–642. https://doi.org/10.1111/jam.12568
Szweda P, Gorczyca G, Filipkowski P, Zalewska M, Milewski S (2014c) Efficient production of Staphylococcus simulans lysostaphin in a benchtop bioreactor by recombinant Escherichia coli. Prep Biochem Biotechnol 44:370–381. https://doi.org/10.1080/10826068.2013.829499
Tossavainen H, Raulinaitis V, Kauppinen L, Pentikäinen U, Maaheimo H, Permi P (2018) Structural and functional insights into lysostaphin-substrate interaction. Front Mol Biosci 5:60. https://doi.org/10.3389/fmolb.2018.00060
Turner NA, Sharma-Kuinkel BK, Maskarinec SA, Eichenberger EM, Shah PP, Carugati M, Holland TL, Fowler VG Jr (2019) Methicillin- resistant Staphylococcus aureus: an overview of basic and clinical research. Natl Rev 17:203–218. https://doi.org/10.1038/s41579-018-0147-4
Vaillancourt K, LeBel G, Yi L, Grenier D (2018) In vitro antibacterial activity of plant essential oils against Staphylococcus hyicus and Staphylococcus aureus, the causative agents of exudative epidermitis in pigs. Arch Microbiol 200:1001–1007. https://doi.org/10.1007/s00203-018-1512-4
van de Kamp M, van den Hooven HW, Konings RN, Bierbaum G, Sahl H-G, Kuipers OP, Siezen RJ, de Vos WM, Hilbers CW, van de Ven FJ (1995) Elucidation of the primary estructure of the lantibiotic epilancin K7 from Staphylococcus epidermidis K7: cloning and characterisation of the epilancin-K7-encoding gene and NMR analysis of mature epilancin K7. Eur J Biochem 230:587–600. https://doi.org/10.1111/j.1432-1033.1995.tb20600.x
van der Hoeven R, Betrabet G, Forst S (2008) Characterization of the gut bacterial community in Manduca sexta and effect of antibiotics on bacterial diversity and nematode reproduction. FEMS Microbiol Lett 286:249–256. https://doi.org/10.1111/j.1574-6968.2008.01277.x
Vyas HKN, Proctor E-J, McArthur J, Gorman J, Sanderson-Smith M (2019) Current understanding of group A Streptococcal biofilms. Curr Drug Targets 20:982–993. https://doi.org/10.2174/1389450120666190405095712
Wang R, Braughton KR, Kretschmer D, Bach TH, Queck SY, Li M, Kennedy AD, Dorward DW, Klebanoff SJ, Peschel A, DeLeo FR, Otto M (2007) Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat Med 13:1510–1514. https://doi.org/10.1038/nm1656
Wang R, Khan BA, Cheung GYC, Bach T-HL, Jameson-Lee M, Kong K-F, Queck SY, Otto M (2011) Staphylococcus epidermidis surfactant peptides promote biofilm maturation and dissemination of biofilm-associated infection in mice. J Clin Invest 121:238–248. https://doi.org/10.1172/JCI42520
Waterhouse A, Bertoni M, Bienert S, Studer G, Tauriello G, Gumienny R, Heer FT, de Beer TAP, Rempfer C, Bordoli L, Lepore R, Schwede T (2018) SWISS-MODEL: Homology modelling of protein structures and complexes. Nucleic Acids Res 46(W1):W296–W303. https://doi.org/10.1093/nar/gky427
Wilaipun P, Zendo T, Okuda K, Nakayama J, Sonomoto K (2008) Identification of the Nukacin KQU-131, a new type-A(II) lantibiotic produced by Staphylococcus hominis KQU-131 isolated from Thai fermented fish product (Pla-ra). Biosci Biotechnol Biochem 72:2232–2235. https://doi.org/10.1271/bbb.80239
Wladyka B, Wielebska K, Wloka M, Bochenska O, Dubin G, Dubin A, Mak P (2013) Isolation, biochemical characterization, and cloning of a bacteriocin from the poultry-associated Staphylococcus aureus strain CH-91. Appl Microbiol Biotechnol 97:7229–7239. https://doi.org/10.1007/s00253-012-4578-y
Wladyka B, Piejko M, Bzowska M, Pieta P, Krzysik M, Mazurek L, Guevara-Lora I, Bukowski M, Sabat AJ, Friedrich AW, Bonar E, Międzobrodzki J, Dubin A, Mak P (2015) A peptide factor secreted by Staphylococcus pseudintermedius exhibits properties of both bacteriocins and virulence factors. Sci Rep 5:14569. https://doi.org/10.1038/srep14569
Xiao H, Chen Y, Liu Z, Huang K, Li W, Cui X, Zhang L, Yi L (2009) Phylogenetic diversity of cultivable bacteria associated with a sea anemone from coast of the Naozhou island in Zhanjiang, China. Acta Microbiol Sin 49:246–250
Xu Q, Bateman A, Finn RD, Abdubek P, Astakhova T, Axelrod HL, Bakolitsa C, Carlton D, Chen C, Chiu H-J, Chiu M, Clayton T, Das D, Deller MC, Duan L, Ellrott K, Ernst D, Farr CL, Feuerhelm J, Grant JC, Grzechnik A, WonHan G, Jaroszewski L, Jin KK, Klock HE, Knuth MW, Kozbial P, Krishna SS, Kumar A, Marciano D, McMullan D, Miller MD, Morse AT, Nigoghossian E, Nopakun A, Okach L, Puckett C, Reyes R, Rife CL, Sefcovic N, Tien HJ, Trame CB, van den Bedem H, Weekes D, Wooten T, Hodgson KO, Wooley J, Elsliger M-A, Deacon AM, Godzik A, Lesley SA, Wilson IA (2010) Bacterial Pleckstrin homology domains: a prokaryotic origin for the PH domain. J Mol Biol 396:31–46. https://doi.org/10.1016/j.jmb.2009.11.006
Xu G, Xing W, Li T, Xue M, Ma Z, Jiang N, Luo L (2019) Comparative study on the effects of different feeding habits and diets on intestinal microbiota in Acipenser baeri Brandt and Huso huso. BMC Microbiol 19:297. https://doi.org/10.1186/s12866-019-1673-6
Xue B, Zhang C, Wang Y, Wang J, Zhang J, Lu M, Li G, Cao ZQ (2014) A novel controlled-release system for antibacterial enzyme lysostaphin delivery using hydroxyapatite/chitosan composite bone cement. PLoS One 9:e113797. https://doi.org/10.1371/journal.pone.0113797
Yan J, Bassler BL (2019) Surviving as a community: Antibiotic tolerance and persistence in bacterial biofilms. Cell Host Microbe 26:15–21. https://doi.org/10.1016/j.chom.2019.06.002
Yang S-C, Lin C-H, Sung CT, Fang J-F (2014) Antibacterial activities of bacteriocins: application in foods and pharmaceuticals. Front Microbiol 5:241. https://doi.org/10.3389/fmicb.2014.00241
Yu W, Kim HK, Rauch S, Schneewind O, Missiakas D (2017) Pathogenic conversion of coagulase-negative staphylococci. Microbes Infect 19:101–109. https://doi.org/10.1016/j.micinf.2016.12.002
Zalewska M, Churey JJ, Worobo RW, Milewski S, Szweda P (2018) Isolation of bacteriocin-producing Staphylococcus spp. strains from human skin wounds, soft tissue infections and bovine mastitis. Pol J Microbiol 67:163–169. https://doi.org/10.21307/pjm-2018-018
Zhang Q, Liu W (2013) Biosynthesis of thiopeptide antibiotics and their pathway engineering. Nat Prod Rep 30:218–226. https://doi.org/10.1039/c2np20107k
Zhao H, Blazanovic K, Choi Y, Bailey-Kellogg C, Griswold KE (2014) Gene and protein sequence optimization for high-level production of fully active and aglycosylated lysostaphin in Pichia pastoris. Appl Environ Microbiol 80:2746–2753. https://doi.org/10.1128/AEM.03914-13
Zhao H, Verma D, Li W, Choi Y, Ndong C, Fiering SN, Bailey-Kellogg C, Griswold KE (2015) Depletion of T cell epitopes in lysostaphin mitigates anti-drug antibody response and enhances antibacterial efficacy in vivo. Chem Biol 22:629–639. https://doi.org/10.1016/j.chembiol.2015.04.017
Zheng Q, Fang H, Liu W (2017) Post-translational modifications involved in the biosynthesis of thiopeptide antibiotics. Org Biomol Chem 15:3376–3390. https://doi.org/10.1039/c7ob00466d
Zheng S, Nagao J, Nishie M, Zendo T, Sonomoto K (2018a) ATPase activity regulation by leader peptide processing of ABC transporter maturation and secretion protein, NukT, for lantibiotic nukacin ISK-1. Appl Microbiol Biotechnol 102:763–772. https://doi.org/10.1007/s00253-017-8645-2
Zheng Y, He L, Asiamah TK, Otto M (2018b) Colonization of medical devices by staphylococci. Environ Microbiol 20:3141–3153. https://doi.org/10.1111/1462-2920.14129
Acknowledgments
FMF is recipient of a special PhD scholarship from Research Support Foundation of Rio de Janeiro (FAPERJ). PCF is recipient of a fellowship from FAPERJ/Brazil.
Funding
MCFB research is presently supported by a fellowship from the National Council for Scientific and Technological Development (CNPq, 303280/2019-0), Brazil.
Author information
Authors and Affiliations
Contributions
All four authors have contributed substantially and directly to the work, helping to develop the concept for the review, performing the literature search and data analysis, writing different sections of the manuscript, and preparing its figures and tables. MCFB put together the different sections. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(PDF 404 kb)
Rights and permissions
About this article
Cite this article
de Freire Bastos, M., Miceli de Farias, F., Carlin Fagundes, P. et al. Staphylococcins: an update on antimicrobial peptides produced by staphylococci and their diverse potential applications. Appl Microbiol Biotechnol 104, 10339–10368 (2020). https://doi.org/10.1007/s00253-020-10946-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00253-020-10946-9